A one-day international summit on innovation, clinical benefits & cost. | View Online
 
2017 | CANCER CARE AT THE CROSSROADS
 
 
 
A One-Day International Summit
on Innovation, Clinical Benefits & Cost
 
Featuring Round Table Discussions with Expert Panelists Hosted by Moderators
 
 
 
 
  Watch CCX2016 Highlights
 
  Get The Program
 
  Register Now
 
Meet the Speakers/Panelists
 
 
STEPHEN EMERSON
 
STEPHEN
EMERSON
 
MD, PhD, Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center
 
MACE ROTHENBERG
 
MACE
ROTHENBERG
 
MD, Senior vice President,
Chief Development Officer, Oncology, Pfizer
Global Product
Development
Pfizer Inc
 
MAUREEN SULLIVAN
 
MAUREEN
SULLIVAN
 
Chief Strategy
Officer, Blue Cross
Blue Shield
Association
 
CLIFF HUDIS
 
CLIFF HUDIS
 
MD, Chief
Executive Officer,
American Society
of Clinical
Oncology (ASCO)
 
Harold Paz
 
HAROLD PAZ
 
MD MS,
Executive Vice President
and Chief Medical Officer,
Aetna
 
ALEXANDER EGGERMONT
 
ALEXANDER
EGGERMONT
 
MD, PhD, Director Gustave Roussy; Chairman, Cancer
Core Europe
 
JEFFREY BENGER
 
JEFFREY
LE BENGER
 
MD, Chairman and
CEO, Summit Medical
Group & Summit
Health Management
 
Frances VISCO
 
FRANCES
VISCO
 
President, National
Breast Cancer
Coalition
 
PETER FINE
 
PETER FINE
 
President and CEO, Banner Health
 
MARYANN CHRISTOPHER
 
MARYANN
CHRISTOPHER
 
MSN, VP, Clinical Operations and Transformation, Horizon Blue Cross Blue Shield of New Jersey
 
RICHARD BARAKAT
 
RICHARD
BARAKAT
 
MD, MBA, Director, Regional Care Network; Vice Chair, Regional Care Network and Affiliations, Memorial Sloan Kettering Cancer Center
RAZELLE KURZROCK
 
RAZELLE
KURZROCK
 
MD,, Senior
Deputy Director,
Clinical Science,
UCSD Moores
Cancer Center
 
GERALD BATIST
 
GERALD
BATIST
 
MD, Director, Segal Cancer Center and McGill Center for Translational Research in Cancer
 
RICHARD SULLIVAN
 
RICHARD
SULLIVAN
 
MD, PhD, Director, Institute for Cancer Policy, King’s
College London
 
ALAN BRYCE
 
ALAN
BRYCE
 
MD, Vice Chair, Division of Hematology and Medical Oncology, Mayo Clinic of Arizona
INDRANIL BAGCHI
 
INDRANIL
BAGCHI
 
PhD, Vice President
and Head, Payer
Insights and Access,
Patient & Health
Impact, Pfizer Inc
 
 
 
Jeffrey L. Weber
 
Jeffrey
L. Weber
 
MD, PhD, Deputy Director, Perlmutter Cancer Center, NYU Langone Medical Center
 
GLEN STETTIN
 
GLEN
STETTIN
 
MD, Chief Innovation Officer & Senior Vice President - Clinical, Research & New Solutions, Express Scripts
 
JOSE FRANCISCO TOMAS MARTINEZ
 
JOSE FRANCISCO
TOMAS MARTINEZ
 
MD, Medical
Executive Director, Sanitas/BUPA, Spain
David  M. Nanus
 
David
M. Nanus
 
MD, Director of New York Presbyterian Hospital - Weill Cornell Medicine Healthcare Services Cancer Program; Chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York Presbyterian
 
Michael J. Fisch
 
Michael
J. Fisch
 
MD, Medical Director of Oncology, AIM Specialty Health
 
Robert S. Miller
 
Robert
S. Miller
 
MD, Vice President and Medical Director, CancerLinQ, American Society of Clinical Oncology (ASCO)
 
JACQUE SOKOLOV
 
GIDEON
BOSKER
 
MD, Co-Founder and Chief Executive Officer, Darwin Health
JACQUE SOKOLOV
 
JACQUE
SOKOLOV
 
MD, Chairman and CEO, SSB Solutions
 
   
RYAN HUBBS
 
RYAN HUBBS
 
Principal, Meyer Consulting
 
MIKE MEYER
 
MIKE MEYER
 
President, Meyer Consulting
 
 
 
Meet The Sponsors
 
  MEYER CONSUTTING   Blue cross Blue Shield   Pfizer Oncology  
 
  Horizon   SUMMIT MEDICAL GROUP   SUMMIT HEALTH MANAGEMENT
 
  Well Cornell Medicine   Columbia Doctors   NewYork Preshyterian  
 
  SSB Solutions  
 
What You Will Learn
 
 
Cancer care delivery and cost through the lens of health plans, academic centers, pharma, and provider groups and what has happened over the last 12 months.
 
 
 
How to leverage the resources and talent of of academic medical centers in collaboration with community physicians.
 
 
 
 
About innovations and challenges facing diagnosis, integrated care, survivorship programs and palliative care.
 
 
 
The challenges facing health plans, providers and governments in financing new innovative cancer treatments in a changing health policy environment.
 
 
 
 
The latest developments in creating new models of care for cancer care.
 
 
 
 
How genomics, precision medicine, immunotherapeutic and biosimilar therapies will change the future of cancer care.
 
 
 
 
New partnerships being formed to facilitate innovation.
 
 
 
 
New partnerships being formed to facilitate innovation.
 
 
 
 
The use of large data and analytics to improve outcomes and reduce cost.
 
 
 
What’s getting in our way of moving forward in these areas.
 
 
 
About The Organizer
 
 
MEYER CONSUTTING   Meyer Consulting is an international health care consulting and recruiting firm that brings leading experts together in collaborative settings to build better health care solutions.

www.meyerconsultinginc.com
 
 
Forward to Friend
 
www.meyerconsultinginc.com
 
About The Venue
 
 
 
The New York Genome Center is a consortium of renowned academic, medical & industry leaders across the globe, focusing on translating genomic research.

www.nygenome.org

101 Avenue of the Americas, New York, NY 10013